Want to join the conversation?
$KSS 2Q15 Call: We successfully amended and extended our revolver for an additional two years from 2018 to 2020. There were no changes to the financial covenants included in the agreement. Absent the effect of loss in our extinguishment of debt, we now expect our earnings per diluted share to be at the low end of our previous guidance of $4.40-4.60
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?